Incubation of isolated rat adipocytes with insulin, vasopressin, or oxytocin increased plasma membranebound protein kinase C (PKC) activity by 100-400%. PKC activity was assayed by a procedure that is virtually background-free, thus permitting assay of protein kinase activity in highly diluted samples of solubilized membranes. Hormonedependent increases in PKC activity were limited to plasma membranes. Stimulation of the kinase was half-maximal with 70 pM insulin, and the hormone effect was rapid. Oxytocin and vasopressin produced effects on PKC similar to insulin, but the magnitude of the vasopressin stimulation exhibited seasonal variations. Treatment of cells with phorbol 12-myristate 13-acetate (PMA) resulted in a loss of PKC activity from the cytosol and a gain in plasma membrane activity, indicative of translocation of the enzyme. With activity measurements it was not possible to determine if insulin stimulated a translocation of the kinase. However, Western blot analysis of plasma membranes with polyclonal antibodies directed against PKC suggest that at least some ofthe insulin-stimulated PKC activity resulted from enzyme translocation.
hand, decreased phorbol ester binding to adipocyte plasma membrane sites, thought to represent PKC, has been observed after treatment of fat cells with insulin (27) .
Like phorbol esters, vasopressin and oxytocin mimic a number of insulin effects on adipocytes (for examples, see refs. 1, [28] [29] [30] . However, in contrast to insulin, stimulation of phospholipid metabolism and diacylglycerol formation in adipocytes by vasopressin and oxytocin is readily detected (20, 21) . Moreover, PKC has been implicated in the actions of these nonapeptide hormones in a variety of cells (for examples, see refs. [31] [32] [33] [34] . Nevertheless, other than a report on activation of hepatic PKC with vasopressin (35) , there appear to be no reports that directly demonstrate increased PKC activity in isolated membranes after exposure of adipocytes or other types of cells to either vasopressin or oxytocin.
In this paper, with the use of a highly sensitive protein kinase assay method (36) , we report that exposure of isolated rat adipocytes to insulin, vasopressin, or oxytocin increases PKC activity in adipocyte plasma membranes.
In 1966 Rodbell (1) noted that "there is some common action of oxytocin, insulin and phospholipase C," based on the observation that, when applied extracellularly, the three agents increased glucose transport and amino acid incorporation into proteins of fat cells. A possible basis for this mimicry of hormones by exogenous phospholipase C lies in the finding that many hormone receptors increase phospholipid turnover, production ofdiacylglycerol, and activation of the calcium-and phospholipid-dependent enzyme, protein kinase C (PKC) (2) (3) (4) , and there is indirect evidence for PKC participation in acute metabolic effects of insulin on adipocytes and other cells. Tumor-promoting phorbol esters, which substitute for diacylglycerol in stimulating PKC (3), increase transport of glucose (5-9) and amino acids (7), activate pyruvate dehydrogenase (7), increase lipogenesis (6, 8, (9) (10) (11) , and stimulate ion transport (12, 13) . Moreover, insulin has been reported to increase phospholipid metabolism (14) (15) (16) and the formation of diacylglycerol in adipose tissue (17) and in cultured myocytes (17) (18) (19) , but there is sharp disagreement on this issue (20, 21) .
Despite the evidence implicating PKC in the acute actions of insulin on adipocytes, data demonstrating increased PKC activity in adipocyte membranes after insulin treatment are notably lacking. In contrast to reported findings of insulinstimulated increased PKC activity in cultured smooth muscle cells (22) Rodbell (28) as modified (37) . Adenosine (200 nM) was included in all incubation media (38 (36) . (GS peptide is a synthetic dodecapeptide of glycogen synthase, NH2-Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys-COOH.) Preliminary studies showed that this substrate concentration was optimal for expressing PKC activity. Phosphatidylserine (PS) and 1,2-diolein (DO) (Avanti Polar Lipids) were prepared as described (36) and added at final concentrations of 100 and 10 gg/ml, respectively. "Basal" is defined as the activity in the presence of EGTA but without the combination of Ca2" plus the lipid mixture. The final assay volume was 100 A.l, of which 10 Al was the adipocyte subcellular fractions as described above. After incubation for 20 min at 30'C, the reaction was stopped and the 32P-labeled GS peptide was purified as described (36 The insulin-dependent increase in PKC activity was rapid (Fig. 2) . Adipocytes were incubated with a supramaximal insulin concentration and, at the indicated times, the cells were introduced into the homogenization medium at 18°C. An insulin-induced increase in plasma membrane PKC activity was evident at the earliest time tested, 0.5 min. However, from the times the cells were removed from the incubation medium, introduced into the homogenization medium, and washed, 1.5-2 min elapsed. Thus, if one includes this washing period, the earliest time tested was 2-2.5 min. By 4 min after initiation of incubations with insulin, or 6 min including the washing time, activation of PKC was maximal. Similar to the data in Fig. 1 (Fig. 3) , which was less than the insulin effect for the experiments presented in Fig. 3 (see below) . Although the magnitude of the insulin response remained relatively constant over a 1-year period, the vasopressin response varied from nil during late autumn and winter to twice the insulin response during the summer (data not shown).
Subcellular Distribution of PKC Activity in Control and Hormone-Treated Adipocytes. The effects of vasopressin, insulin, and PMA on the subcellular distribution of GSpeptide phosphorylating activities were examined (Table 1) . In contrast to other experiments in this study, the protein kinase assays shown in Table 1 (39) show that the hormonal increases in PKC occur at the plasma membrane.
Typically, activation of PKC by various hormones in their respective target cells is revealed after ion-exchange chromatography of solubilized membranes (41) . Apparently, insulin-mediated activation of adipocyte PKC is not detected by these standard procedures (12, 24) or by alternate methods (25, 26) . It is possible that the positive effects reported in this (42, 43) . Interestingly, the insulin-induced increase in PKC activity in diaphragm and cultured myocytes is not accompanied by a parallel loss in cytosolic activity (22, 23) . Until (47) and lipogenesis (48) parallels their inhibition of PKC. On the other hand, PKC activation does not fully mirror the insulin effect, as shown by differences between phorbol ester-and insulin-stimulated translocation of the glucose transporter and activation of glucose transport (49 (49) . In any event, it seems reasonable to condude that PKC activation is an early event mediated by occupation of the adipocyte insulin receptor and this enzyme should be added to the list of protein kinases that catalyze phosphorylation of serine and threonine residues after insulin receptor activation (50, 51) .
In view of the stimulation of phosphatidylinositol breakdown (20) and diacylglycerol formation (21) 
